The burgeoning landscape of innovative treatments for metabolic management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a https://laramijg933171.wikilentillas.com/1965069/retatrutide_vs_tirzepatide_a_comparative_analysis